INDIA MARKET LENS
Companies2 outlets▼ NegativeInstitutional Flows

Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore

Anthem Biosciences moved lower in an institutional flows development for FY27 with October 9 in focus.

· ET Stocks, Economic Times Markets

Portsmouth Technologies LLC executed a block deal selling 30 lakh shares of Anthem Biosciences on October 9. The shares were sold at Rs 833 each, totaling Rs 249.90 crore. Following this transaction, Portsmouth's estimated stake in the company would decrease significantly. Anthem Biosciences reported a decline in total income and profit after tax for the first quarter of FY27.

Period
FY27
Dates in focus
October 9

Anthem Biosciences reported Rs 250 crore and Rs 833 for FY27. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.

Against that, the stock is -1.2% on the day at ₹862.30, and has returned +15.4% over three months. It sits 10% below its 52-week high. The pharma & healthcare sector has moved -1.4% over the same period, so Anthem Biosciences is running 16.8 points ahead of its peers.

This is a Promoter stake / pledge event. Promoters transact with better information than the market. Direction against the price trend is the signal — accumulation into weakness reads differently from a sale into strength. On the day the stock is -1.2%, so a modest reaction.

  • Sustained FII or DII direction moves the whole market, not just the names being bought — it sets the tape's tone.
  • The company directly in focus is ANTHEM.
  • Sector exposure: Pharma & Healthcare.
  • The immediate tone of coverage reads negative.
ANTHEMPharma & Healthcare